论文部分内容阅读
目的观察黄芪联合HAART治疗艾滋病患者CD4+T淋巴细胞的变化动态。方法收集62例艾滋病患者分为黄芪联合HAART治疗组30例和常规HAART治疗组32例,各治疗24周,观察两组患者在治疗前及治疗后第1、3、6个月时外周血中CD4+T淋巴细胞的动态变化。结果经1、3、6个月治疗后两组CD+4T淋巴细胞均有不同程度提高,与治疗前比较,差异有统计学意义(P<0.05)。两组间比较,经3、6个月治疗后黄芪联合HAART治疗CD4+T淋巴细胞明显高于常规HAART治疗组,差异有统计学意义(P<0.05)。结论较单纯HARRT治疗而言,黄芪联合HAART治疗能更有效提高CD4+T淋巴细胞数量,增强艾滋病患者免疫力。
Objective To observe the changes of CD4 + T lymphocytes in patients with AIDS treated with Astragalus and HAART. Methods Sixty-two AIDS patients were divided into astragalus combined with HAART group and HAART group, 30 cases were treated by conventional HAART for 24 weeks. Before and after treatment, The dynamic changes of CD4 + T lymphocytes. Results After 1, 3, and 6 months of treatment, CD + 4 T lymphocytes in both groups were increased to some extent, with statistical significance (P <0.05). The comparison of the two groups showed that the treatment of asthma combined HAART with CD4 + T lymphocytes after 3 and 6 months of treatment was significantly higher than that of the conventional HAART group (P <0.05). Conclusion Compared with pure HARRT treatment, Astragalus combined with HAART treatment can effectively increase the number of CD4 + T lymphocytes and enhance the immunity of AIDS patients.